Overview

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Long-term observational study to assess the safety, efficacy and quality of life of patients with neovascular age-related macular degeneration (AMD) under Macugen treatment.
Details
Lead Sponsor:
Pfizer